Cite
HARVARD Citation
Lu, H. et al. (2016). Primary tumor location is an important predictive factor for wild‐type KRAS metastatic colon cancer treated with cetuximab as front‐line bio‐therapy. Asia-Pacific journal of clinical oncology. 12 (3), pp. 207-215. [Online].